Treatment of chronic pain with antiepileptic drugs: A new era

Southern Medical Journal

Volumn 92, Issue 7, 1999, Pages 642-649

  Hansen, Hans C ^a,b,c  

^a Davis Medical Center   (United States)

^b The Pain Relief Centers   (United States)

^c Pain Relief Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; FLUOXETINE; GABAPENTIN; HISTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PAROXETINE; PHENYTOIN; PROSTAGLANDIN E1; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUBSTANCE P; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROIC ACID;

ALOPECIA; ANALGESIC ACTIVITY; ANTICONVULSANT ACTIVITY; APLASTIC ANEMIA; ARTICLE; CHRONIC PAIN; DROWSINESS; DRUG MECHANISM; DRUG SAFETY; EPILEPSY; GASTROINTESTINAL TOXICITY; GINGIVA HYPERPLASIA; HUMAN; INSOMNIA; NEUROPHYSIOLOGY; RASH; SEIZURE; STEVENS JOHNSON SYNDROME; TREMOR;

ACETIC ACIDS; AMINES; ANALGESICS; ANTICONVULSANTS; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURONS, AFFERENT; NOCICEPTORS; PAIN; RECEPTORS, OPIOID; SPINAL NERVE ROOTS;

EID: 0032791437     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199907000-00001     Document Type: Article

References (66)

1. Markenson JA: Mechanisms of chronic pain. Am J Med 1996; 101(suppl 1A):6S-18S
2. Bonica JJ: The Management of Pain. Philadelphia, Lea & Febiger, Vol 1, 1990
3. Insel PA: Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Milinoff PB, Ruddon RW (eds). New York, McGraw-Hill, 1996, pp 617-657
4. France RD: The future for antidepressants: treatment of pain. Psychopathology 1987; 20(suppl 1):99-113
5. Egbunike IG, Chaffee BJ: Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 1990; 10:262-270
6. Goodman WK, Charney DS: Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs. J Clin Psychiatry 1985; 46:6-22
7. Leijon G, Boivie J: Central post-stroke pain. a controlled trial of amitriptyline and carbamazepine. Pain 1989; 36:27-36
8. Onghena P, VanHoudenhove B: Antidepressant-induced analgesia in chronic nonmalignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49:205-219
9. Ward NG: 1986 Volvo Award in Clinical Sciences: Tricyclic antidepressants for chronic low-back pain. mechanisms of action and predictors of response. Spine 1986; 11:661-665
10. Wright JM: Review of the symptomatic treatment of diabetic neuropathy. Pharmacotherapy 1994; 14:689-697
11. Baldessarini RJ: Drugs and the treatment of psychiatric disorders. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Milinoff PB, Ruddon RW (eds). New York, McGraw-Hill, 1996, pp 431-459
12. Twycross RG: Narcotics. Textbook of Pain. Wall PD, Melzack R (eds). New York, Churchill-Livingstone, 1984, pp 514-525
13. Kanjhan R: Review: opioids and pain. Clin Exp Pharmacol Physiol 1995; 22:397-403
14. Chadda VS, Mathur MS: Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy. J Assoc Physicians India 1978; 26:403-406
15. Harkins S, Linford J, Cohen J, et al: Administration of clonazepam in the treatment of TMD and associated myofascial pain: a double-blind pilot study. J Craniomandib Disord Facial Oral Pain 1991; 5:179-186
16. Stensrud P, Sjaastad O: Clonazepam (Rivotril) in migraine prophylaxis. Headache 1979; 19:333-334
17. Farago F: Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol 1987; 26:73-83
18. Rompel H, Bauermeister PW: Etiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study. S Afr Med J 1970; 24:75-80
19. Moosa RS, McFadyen ML, Miller R, et al: Carbamazepine and its metabolites in neuralgias: concentration-effect relations. Eur J Clin Pharmacol 1993; 45:297-301
20. Rothrock JF, Kelly NM, Brody ML, et al: A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia 1994; 14:241-244
21. Rasmussen P, Riishede J: Facial pain treated with carbamazepine (Tegretol). Acta Neurol Scand 1970; 46:385-408
22. Imamura Y, Bennett GJ: Felbamate relieves several abdominal pain sensations in rats with an experimental peripheral neuropathy. J Pharmacol Exp Ther 1995; 275:177-182
23. Shibasaki H, Tabira T, Inoue N, et al: Carbamazepine for painful crises in Fabry's disease. J Neurol Sci 1973; 18:47-51
24. Mathew NT, Ali S: Valproate in the treatment of persistent chronic daily headache. an open label study. Headache 1991; 31:71-74
25. Gerson GR, Jones RB, Luscombe DK: Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia. Postgrad Med J 1977; 53(suppl 4):104-109
26. Hering K, Kuritzky A: Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992; 12:81-84
27. Cutrer FM, Moskowitz MA: The actions of valproate and neurosteroids in a model of trigeminal pain. Headache 1996; 36:579-585
28. Rull JA, Quibrera R, González-Millán H, et al: Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double-blind crossover trial. Diabetologia 1969; 5:215-218
29. Saudek CD, Werns S, Reidenberg MM: Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977; 22:196-199
30. Arieff AJ, Wetzel N: Tegretol in the treatment of neuralgias. Dis Nerv System 1967; 28:820-823
31. Bhatia MT: Anticonvulsant alone in the relief of cancer pain. J Indian Med Assoc 1992; 90:301-302
32. Yajnik S, Singh GP, Singh G, et al: Phenytoin as a coanalgesic in cancer pain. J Pain Symptom Manage 1992; 7:209-213
33. Westerholm N: Treatment of facial pain with G 32 883 (Tegretol, Geigy). Scand J Dent Res 1970; 78:144-148
34. Killian JM, Fromm GH: Carbamazepine in the treatment of neuralgia: use and side effects. Arch Neurol 1968; 19:129-136
35. Campbell FG, Graham JG, Zilkha KJ: Clinical trial of carbamazepine (Tegretol)) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966; 29:265-267
36. Siddall PJ, Cousins MJ: Pain mechanisms and management: an update. Clin Exp Pharmacol Physiol 1995; 22:679-688
37. Laxer KD: Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin. West J Med 1994; 161:309-314
38. Mattson MH: Efficacy and adverse effects of established and new antiepileptic drugs. Epilepsia 1995; 36(suppl):S13-S26
39. Sabers A, Gram L: Drug treatment of epilepsy in the 1990s: achievements and new developments. Drugs 1996; 52:483-493
40. Lundeberg T: Pain physiology and principles of treatment. Scand J Rehabil Med 1995; 32:13-42
41. Katz WA: Approach to the management of nonmalignant pain. Am J Med 1996; 101(suppl 1A):54S-63S
42. McCormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994; 59:9-43
43. DiPalma JR, DiGregorio GJ: Management of low back and neck pain by analgesics and adjuvant drugs: an update. Mt Sinai J Med 1994; 61:193-196
44. Turner JA, Denny MC: Do antidepressant medications relieve chronic low back pain? J Farm Pract 1993; 37:545-553
45. Marcus DA: Serotonin and its role in headache pathogenesis and treatment Clin J Pain 1993; 9:159-167
46. Olin BR: Drug Facts and Comparisons. St. Louis, Facts and Comparisons, 1997
47. Raffa RB: A novel approach to the pharmacology of analgesics. Am J Med 1996; 101(supp1 1A):40S-46S
48. Katz WA: Pharmacology and clinical experience with tramadol in osteoarthritis. Drugs 1996; 52(suppl 3):39-47
49. Aronson MD: Nonsteroidal anti-inflammatory drugs, traditional opioids, and tramadol: contrasting therapies for the treatment of chronic pain. Clin Ther 1997; 19:420-432
50. Xi ZX, Akasu T: Presynaptic GABA receptors in vertebrate synapses. Kurume Med J 1996; 42:115-122
51. Misgeld U, Jarolimek W, Bijak M: A physiological role for GABA receptors and the effects of baclofen in the mammalian central nervous system. Prog Neurobiol 1995; 46:423-462
52. Fromm GH: Baclofen as an adjuvant analgesic. J Pain Symptom Manage 1994; 9:500-509
53. Fromm GH, Terrence CF, Chattha AS: Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol 1984; 15:240-244
54. Hobbs WR, Rall TW, Verdoorn TA: Hypnotics and sedatives; ethanol. Goodman & Gilman's The Pharmacological Basis of Therapeutics. Milinoff PB, Ruddon RW (eds). New York, McGraw-Hill, 1996, pp 617-657
55. Reddy S, Patt RB: The benzodiazepines as adjuvant analgesics. J Pain Symptom Manage 1994; 9:510-514
56. MacDonald RL, Kelly KM: Antiepileptic drug mechanisms of action. Epilepsia 1995; 36(suppl 2):S2-S12
57. White HS: Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia 1997; 38(suppl 1):S9-S17
58. Meldrum BS: The role of glutamate in epilepsy and other CNS disorders. Neurology 1994; 44(suppl 8):S14-S23
59. Goa KL, Sorkin EM: Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy. Drugs 1993; 46:409-427
60. Reimann W: Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 1983; 94:341-344
61. Schlicker E, Reimann W, Göthert M: Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Drug Res 1985; 35:1347-1349
62. Suman-Chahan N, Webdale L: Characterisation of [H3] gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol (Molecular Pharmacol Section) 1993; 244:293-301
63. Mellick GA, Mellick LB: Successful treatment of restless leg syndrome with gabapentin (Neurontin) (Abstract 446S). Neurology 1995; 45(suppl 4):A285
64. Burrows GT, King RB: Gabapentin in essential tremor (Abstract 106P). Neurology 1995; 45(suppl 4):A187
65. Mellick GA, Mellick LB: Reflex sympathetic dystrophy treated with gabapentin. Arch Phys Med Rehabil 1997; 78:98-105
66. Fields HL, Martin JB: Pain: pathophysiology and management. Harrison's Principles of Internal Medicine. Isselbacher K, Brunwald E, Wilson JD, et al (eds). New York, McGraw-Hill, 1994, pp 49-55